Regenerative Medicine

Selected news for the healthcare topic - Regenerative Medicine, collected since 10/2017. Recent stories appear in Yahoo News and speakingaboutnews.com. This healthcare topic shares news with Stem Cell Research, Denver, Colorado, Cell Therapy, Biotech, Food and Drug Administration and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
5/26/2021 Scaffold Technology Market Size Worth $2.1 Billion By 2028 | CAGR: 8.4%: Grand View Research, Inc. Yahoo News ... to its increasing adoption rateThe nanofiber-based scaffolds segment is expected to witness lucrative growth owing to the growing advancements such as 3D molding for developing 3D nanofiber membranesThe stem cell therapy, regenerative medicine , and tissue engineering segment held the largest revenue share in 2020This growth is attributed to the expanding adoption of scaffolds in the aesthetic procedure, wound healing, periodontology, and colorectal surgeriesThe drug discovery ...
5/26/2021 Facebook removed a comment by a doctor on the number of COVID-19 pediatric deaths speakingaboutnews.com ... the comment violated it “Community Standards on Spam.” A Facebook user asked about the number of COVID-19 pediatric deaths in the month of April. Dr. Tracy Høeg, a sports, spine, and regenerative medicine doctor, responded with factual information from the CDC and American Academy of Pediatrics (AAP), and even included a graph.“Part of the reason I have (for the most part) left Facebook is they delete ...
5/26/2021 Contrasting Athersys (NASDAQ:ATHX) and ASLAN Pharmaceuticals (NASDAQ:ASLN) rivertonroll.com ... Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.About AthersysAthersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine . Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell ...
5/26/2021 Humacyte Receives 2021 Life Sciences Award from Triangle Business Journal forextv.com ... extraordinary organizations in North Carolina that are transforming the life sciences industry,” said Laura Niklason, M.D., Ph.D., Chief Executive Officer of Humacyte. “This award highlights Humacyte’s dedication to becoming a leader in regenerative medicine by pioneering the development of our first-in-class bioengineered human tissue, made possible by our talented team and the support of a thriving local life sciences ecosystem.”Humacyte develops and manufactures acellular ...
5/26/2021 The Ridgway Record ridgwayrecord.com ... extraordinary organizations in North Carolina that are transforming the life sciences industry,” said Laura Niklason, M.D., Ph.D., Chief Executive Officer of Humacyte. “This award highlights Humacyte’s dedication to becoming a leader in regenerative medicine by pioneering the development of our first-in-class bioengineered human tissue, made possible by our talented team and the support of a thriving local life sciences ecosystem.”Humacyte develops and manufactures acellular ...
5/26/2021 Humacyte Receives 2021 Life Sciences Award from Triangle Business Journal Globe Newswire ... extraordinary organizations in North Carolina that are transforming the life sciences industry,” said Laura Niklason, M.D., Ph.D., Chief Executive Officer of Humacyte. “This award highlights Humacyte’s dedication to becoming a leader in regenerative medicine by pioneering the development of our first-in-class bioengineered human tissue, made possible by our talented team and the support of a thriving local life sciences ecosystem.”Humacyte develops and manufactures acellular ...
5/26/2021 Humacyte Receives 2021 Life Sciences Award from Triangle Business Journal tmcnet.com ... extraordinary organizations in North Carolina that are transforming the life sciences industry,” said Laura Niklason, M.D., Ph.D., Chief Executive Officer of Humacyte. “This award highlights Humacyte’s dedication to becoming a leader in regenerative medicine by pioneering the development of our first-in-class bioengineered human tissue, made possible by our talented team and the support of a thriving local life sciences ecosystem.”Humacyte develops and manufactures acellular ...
5/26/2021 The global regenerative medicine market revenue is likely to grow to $39,012.0 million by 2030 from $8,186.9 million in 2019, at a 16.3% CAGR between 2020 and 2030 Yahoo News ... utm_source=GNWOver 17.9 million people die of cardiovascular diseases (CVDs) and 9.6 million of cancer each year, says the World Health Organization (WHO). With the mortality rate increasing every year, the global regenerative medicine market revenue is likely to grow to $39,012.0 million by 2030 from $8,186.9 million in 2019, at a 16.3% CAGR between 2020 and 2030.This is because regenerative medicine is focused on repairing and ...
5/26/2021 The global regenerative medicine market revenue is likely to grow to $39,012.0 million by 2030 from $8,186.9 million in 2019, at a 16.3% CAGR between 2020 and 2030 Globe Newswire The global regenerative medicine market revenue is likely to grow to $39,012.0 million by 2030 from $8,186.9 million in 2019, at a 16.3% CAGR between 2020 and 2030 Regenerative Medicine Market Research Report: By Type (Cell Therapy, Gene Therapy, Tissue Engineered Products), Application (Musculoskeletal, Wound Care, Oncology, Dental, Ocular) - Global Industry Analysis and Demand Forecast to 2030 May 26, 2021 10:59 ET ReportLinker Lyon, FRANCENew York, May 26, 2021 ...
5/26/2021 The global regenerative medicine market revenue is likely to grow to $39,012.0 million by 2030 from $8,186.9 million in 2019, at a 16.3% CAGR between 2020 and 2030 Yahoo News ... utm_source=GNWOver 17.9 million people die of cardiovascular diseases (CVDs) and 9.6 million of cancer each year, says the World Health Organization (WHO). With the mortality rate increasing every year, the global regenerative medicine market revenue is likely to grow to $39,012.0 million by 2030 from $8,186.9 million in 2019, at a 16.3% CAGR between 2020 and 2030.This is because regenerative medicine is focused on repairing and ...
5/26/2021 Collagen and Gelatin Market for Regenerative Medicine – Geographical Analysis and Leading Key Players express-press-release.net LinkedIn 0PUNE, India, 2021-May-26 — /EPR Network/ — The report “ Collagen and Gelatin Market for Regenerative Medicine (by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular)), Value and Volume Analysis – Global Forecast”.The global collagen market for regenerative medicine is projected to reach $679.9 Million, at a CAGR of 10.1% during the forecast period.The global gelatin market for regenerative medicine is projected ...
5/25/2021 MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2021 Annual Meeting of Shareholders Globe Newswire ... on How to Pre-RegisterMARIETTA, Ga., May 25, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine , today reminded shareholders to pre-register for the upcoming 2021 Annual Meeting of Shareholders (“Annual Meeting”), by no later than 10:00 a.m. Eastern on Wednesday, May 26, 2021.In order to attend the ...
5/25/2021 Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived NRXN1-mutant neurons [Neuroscience] pnas.org ... CA 94305; b Howard Hughes Medical Institute, Stanford University School of Medicine , Stanford, CA 94305; c Department of Biochemistry & Molecular Biology, University of Massachusetts , Amherst, MA 01003; d Institute for Stem Cell Biology and Regenerative Medicine , Stanford University School of Medicine , Stanford, CA 94305; e Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School , New Brunswick, NJ 08901; f Department of Neuroscience and Cell Biology, Rutgers Robert ...
5/25/2021 Organicell To Present Results Of Zofin Clinical Studies At The International Society Of Cell And Gene Therapy Annual Meeting | Financial Buzz financialbuzz.com Organicell Regenerative Medicine , Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced that the Company will be presenting at the annual meeting of the International Society of Cell and Gene Therapy (ISCT) taking place on May 26-28, 2021.Organicell’s work, which was selected for an oral presentation, will be part of a session titled: “ EVs for Infectious Diseases and Preparedness ...
5/25/2021 Decibel Therapeutics Expands World-Class Scientific Advisory Board firstwordpharma.com ... our SAB bring a deep understanding of the genetic roots of hearing loss and balance disorders, and we look forward to working closely with them as we progress our pipeline of gene therapies and regenerative medicine s," said Joe Burns, Ph.D., Vice President, Discovery."We value their insights and tremendous experience in the translational considerations for the development of gene therapies as Decibel works to address the vast unmet needs in ...
5/24/2021 Cryoport Further Expands its Asia Pacific Operations with New Global Logistics Center in Singapore worldpharmatoday.com ... solutions, with capabilities covering the full temperature range from -196° Celsius and every single gradient, up to and including Controlled Room Temperature (CRT).As of March 31, 2021, Cryoport supported 543 clinical trials in regenerative medicine globally, with 28 of those clinical trials being in the APAC region. An important example of growing demand in Singapore is driven by our partner, Lonza, which has a key clinical and commercial cell ...
5/24/2021 BioStem Technologies Announces Filing of 2021 First Quarter Financial Reports Globe Newswire ... a shift in product mix to our higher gross margin products. About BioStem Technologies, Inc. (OTC PINK: BSEM): BioStem Technologies, Inc. is a global life sciences corporation, providing innovative technologies with a concentration in Regenerative Medicine . The company's mission is to discover, develop and produce the most effective Regenerative Medicine products in the world. BioStem Technologies offers a comprehensive portfolio of high-quality brands that include RHEO ‚Ñ¢ , VENDAJE ‚Ñ ...
5/24/2021 Column: California's stem cell program found a disease cure, but it's being blocked by a biotech firm newsbreak.com ... normal life. But she’s also anguished.Anguished not by doubts about the treatment, which was funded with millions of dollars from California’s stem cell program formally known as the California Institute for Regenerative Medicine , or CIRM.The treatment has completely cured Evangelina’s rare genetic immune system deficiency, which is known familiarly as bubble baby syndrome and commonly takes the lives of children with the condition by the ...
5/24/2021 Decibel Therapeutics Expands World-Class Scientific Advisory Board Globe Newswire ... our SAB bring a deep understanding of the genetic roots of hearing loss and balance disorders, and we look forward to working closely with them as we progress our pipeline of gene therapies and regenerative medicine s,” said Joe Burns, Ph.D., Vice President, Discovery.“We value their insights and tremendous experience in the translational considerations for the development of gene therapies as Decibel works to address the vast unmet needs ...
5/23/2021 BioRestorative Therapies (OTCMKTS:BRTX) & SOC Telemed (NASDAQ:TLMD) Head to Head Analysis - American Banking News American Banking News ... Therapies.SummarySOC Telemed beats BioRestorative Therapies on 6 of the 11 factors compared between the two stocks.BioRestorative Therapies Company ProfileBioRestorative Therapies, Inc., a life sciences company focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program ...